by Dylan Berman | Mar 27, 2026 | General
Artelo Biosciences, Inc. (NASDAQ:ARTL) shares are trading higher Friday after the company announced the withdrawal of its SEC Registration Statement as it doesn’t intend to sell securities at this time. Artelo Biosciences stock is surging to new heights today. Why is...
by Anusuya Lahiri | Mar 27, 2026 | General
Meta Platforms, Inc. (NASDAQ:META) is doubling down on its U.S. infrastructure footprint, unveiling plans to expand its El Paso, Texas data center to 1 gigawatt, a move that will push total investment beyond $10 billion while creating hundreds of long-term jobs. Data...
by Avi Kapoor | Mar 27, 2026 | General
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. BTIG analyst Gregory Lewis initiated coverage on Iperionx Ltd...
by Avi Kapoor | Mar 27, 2026 | General
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Barclays analyst Glen Santangelo upgraded Phathom Pharmaceuticals...
by Eva Mathew | Mar 27, 2026 | General
The Iran war has already set the stage for elevated petrochemical prices through year-end, and the supply chain damage could take the better part of a year to unwind, Dow chairman and CEO Jim Fitterling said. Speaking at the CERAWeek by S&P Global conference in...
by Vandana Singh | Mar 27, 2026 | General
Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) shares are up during Friday’s premarket session following the FDA’s accelerated approval of Kresladi (marnetegragene autotemcel), the first gene therapy for children with severe leukocyte adhesion deficiency-I (LAD-I). FDA...
Recent Comments